The Technical Analyst
Teladoc Health Inc [TDOC]
Exchange: NYSE Sector: Healthcare Industry: Healthcare - Information Services
Teladoc Health Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-5.28% $12.20
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 068.97 mill |
| EPS: | -1.410 |
| P/E: | -8.65 |
| Earnings Date: | Jul 23, 2024 |
| SharesOutstanding: | 169.59 mill |
| Avg Daily Volume: | 5.39 mill |
| RATING 2024-05-08 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -8.65 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.13x |
| Company: PE -8.65 | industry: PE 67.77 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 11.64 - 12.76 ( +/- 4.60%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-05-04 | Cave James L. | Sell | 0 | Common Stock |
| 2024-05-04 | Cave James L. | Sell | 1 493 | Employee Stock Option (right to buy) |
| 2024-05-04 | Cave James L. | Sell | 15 000 | Restricted Stock Units |
| 2024-05-01 | Kornwasser Laizer | Sell | 20 198 | Restricted Stock Units |
| 2024-05-01 | Kornwasser Laizer | Buy | 20 198 | Common Stock |
| INSIDER POWER |
|---|
| 50.76 |
| Last 100 transactions |
| Buy: 1 325 089 | Sell: 433 737 |
Forecast:
16:00 - $12.20
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $12.20
Forecast 2: 16:00 - $12.20
Forecast 3: 16:00 - $12.20
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $12.20 (-5.28% ) |
| Volume | 5.29 mill |
| Avg. Vol. | 5.39 mill |
| % of Avg. Vol | 98.05 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For TDOC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
TDOC
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Last 10 Buy Signals
Latest Press Releases
2024-05-08 07:20:00 - Press Release
Levi & Korsinsky Investigates Possible Securities Fraud Violations By Teladoc Health, Inc. (tdoc)
New york, ny / accesswire / may 8, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of teladoc health, inc. ("teladoc") (nyse:tdoc) concerning possible violations of federal securities laws. on february 20, 2024, teladoc announced its fourth quarter and full year results for the period ended december 31, 2023.
2024-05-07 07:30:00 - Press Release
Teladoc Health, Inc. Investigated By Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - Tdoc
New york, ny / accesswire / may 7, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of teladoc health, inc. ("teladoc") (nyse:tdoc) concerning possible violations of federal securities laws. on february 20, 2024, teladoc announced its fourth quarter and full year results for the period ended december 31, 2023.
2024-05-06 07:25:00 - Press Release
Teladoc Health, Inc. (tdoc) Investors With Losses Are Urged To Contact Levi & Korsinsky To Discuss Their Rights
New york, ny / accesswire / may 6, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of teladoc health, inc. ("teladoc") (nyse:tdoc) concerning possible violations of federal securities laws. on february 20, 2024, teladoc announced its fourth quarter and full year results for the period ended december 31, 2023.
2024-05-03 07:20:00 - Press Release
Tdoc Alert- Levi & Korsinsky Has Commenced An Investigation On Behalf Of Teladoc Health, Inc. Shareholders Who Lost Money
New york, ny / accesswire / may 3, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of teladoc health, inc. ("teladoc") (nyse:tdoc) concerning possible violations of federal securities laws. on february 20, 2024, teladoc announced its fourth quarter and full year results for the period ended december 31, 2023.
2024-05-02 07:20:00 - Press Release
Levi & Korsinsky Reminds Teladoc Investors Of The Ongoing Investigation Into Potential Violations Of Securities Laws - Tdoc
New york, ny / accesswire / may 2, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of teladoc health, inc. ("teladoc") (nyse:tdoc) concerning possible violations of federal securities laws. on february 20, 2024, teladoc announced its fourth quarter and full year results for the period ended december 31, 2023.
Latest News
2024-05-08 10:02:19 - Zacks Investment Research
Here is What to Know Beyond Why Teladoc Health, Inc. (TDOC) is a Trending Stock
Teladoc (TDOC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2024-05-02 06:00:00 - InvestorPlace
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
For a time, Cathie Wood was the hottest investor on Wall Street. Ark Invest was bringing in billions of dollars in new assets under management.
2024-04-30 13:41:06 - Zacks Investment Research
Teladoc Health (TDOC) Q1 Loss Widens on Decline in Visits
Teladoc Health's (TDOC) Q1 results suffer from weak contributions from the BetterHelp unit. Management expects U.S. Integrated Care Members of 92-94 million for 2024, up from the prior mentioned 90-92 million.
2024-04-26 18:20:55 - The Motley Fool
Why Teladoc Health Stock Dived on Friday
Teladoc's latest quarterly performance didn't meet expectations. It posted a loss of almost $82 million for the period.
2024-04-25 20:57:07 - Seeking Alpha
Teladoc Health, Inc. (TDOC) Q1 2024 Earnings Call Transcript
Teladoc Health, Inc. (NYSE:TDOC ) Q1 2024 Earnings Call Transcript April 25, 2024 5:00 PM ET Company Participants Adam Vandervoort - Chief Legal Officer Mala Murthy - Acting Chief Executive Officer and Chief Financial Officer Laizer Kornwasser - President of Enterprise Growth and Global Markets. Conference Call Participants Stephanie Davis - Barclays Lisa Gill - JPMorgan Jailendra Singh - Truist Jessica Tassan - Piper Sandler Sean Dodge - RBC Capital Allen Lutz - Bank of America Sarah James - Cantor Fitzgerald George Hill - Deutsche Bank Elizabeth Anderson - Evercore Daniel Grosslight - Citi Operator Good afternoon.
2024-04-25 19:01:32 - Zacks Investment Research
Teladoc (TDOC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
2024-04-25 18:30:18 - Zacks Investment Research
Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.37 per share a year ago.
2024-04-23 12:36:04 - Zacks Investment Research
Can Higher Visits Soften Cost Blow for Teladoc (TDOC) in Q1?
Teladoc's (TDOC) first-quarter results are expected to have benefited from higher visits. However, high costs might have partially offset the positives.
2024-04-19 07:45:00 - The Motley Fool
Should You Buy This Beaten-Down Stock?
Teladoc's business peaked during the early days of the pandemic but has been struggling since. The company does have several things going its way, including a long runway in its industry.
2024-04-17 19:21:12 - Zacks Investment Research
Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Teladoc (TDOC) closed at $13.14, marking a +0.08% move from the previous day.